Lilly will hope that Foundayo continues to dominate and grow over Novo Nordisk in the obesity drug market. Credit: Michael Vi / Shutterstock.com. The US Food and Drug Administration (FDA) has approved Eli Lilly’s orforglipron pill for weight loss, ending Novo Nordisk’s first mover profits in the US after just three months. Oral glucagon-like peptide-1 … Read more
Item 1 of 2 The Zepbound injection pen, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023. REUTERS/Brendan McDermid/ File Photo [1/2]Zepbound syringes, Eli Lilly’s weight loss drug, are displayed in New York City, U.S., December 11, 2023. REUTERS/Brendan McDermid/ File Photo Purchase Licensing RIGHTSopen a new tab April … Read more
If the number on the scale has gone down, it may not be for the reason you want. Most of the time, when you aim to lose weight, you may be looking for fat loss, or reduce excess body fat to change your appearance or improve your health and quality of life, says Dympna Gallagher, … Read more
4 minutes to read If it seems like new medications for weight loss are coming out at a fast rate, that’s because. The first GLP-1 oral pills became available earlier this year. Now, a new oral GLP-1 from drug company Eli Lilly—called Foundayo (orforglipron)—has just won FDA approval. Wajahat Mehal, MD, Medical Director of the … Read more
The US Food and Drug Administration on Wednesday approved a second GLP-1 pill for weight loss, adding another option to its rapidly growing arsenal of obesity therapies. The orforglipron pill, called Foundayo, is made by Eli Lilly, which also sells the GLP-1 drugs Zepbound for obesity and Mounjaro for diabetes. It is given as a … Read more
The US Food and Drug Administration has approved it Eli LillyPills GLP-1 ‘s, said the company, a major milestone for the Indianapolis-based drugmaker and one that will test the market for new weight loss medications. Lilly said the once-daily pill, Foundayo, will begin shipping from LillyDirect’s direct-to-consumer platform on Monday and will be available in … Read more
BEIJING, April 01, 2026–(BUSINESS WIRE)–Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Pharmacy; HKEX: 00460). Under the agreement, both parties will combine Biocytogen’s fully human antibody discovery platform with Sihuan Pharmaceutical’s extensive capabilities in drug development, manufacturing, and commercialization. The collaboration will focus on advancing innovative therapies in multiple disease areas, including weight loss, leveraging complementary strengths to … Read more
Economists at ING have released a new report on the expected impact of appetite weight loss medications on European food demand. Insights reveal how much GLP-1 drugs will impact and reshape the industry in the coming years. GLP-1 drugs are widely discussed as potentially transformative for food consumption, but their short-term impact in 2026 is … Read more
Your support helps us tell the story From reproductive rights to climate change to Big Tech, The Independent is on the ground as stories develop. Whether it’s investigating the finances of Elon Musk’s pro-Trump PAC or producing our latest documentary, ‘The A Word’, which highlights American women fighting for reproductive rights, we know how important … Read more
The NHS in England offers more than 1 million people weight loss drugs to reduce the risk of heart attack and stroke. Semaglutide (Wegovy) is already available over the counter for some people living with obesity, and is also offered under the brand name Ozempic to treat type 2 diabetes. Now people who are not … Read more